Related Experiment Video
Updated: May 1, 2026
03:47
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
471
H pylori recurrence after successful eradication.
World Journal of Gastroenterology
|March 12, 2008
Summary
Helicobacter pylori recurrence is uncommon in developed nations but frequent in developing ones. While recrudescence causes most recurrences in developed countries, reinfection is more prevalent in developing nations, necessitating distinct follow-up strategies.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Epidemiology
Background:
- Helicobacter pylori (H. pylori) recurrence rates differ significantly between developed and developing countries.
- Recurrence is primarily attributed to recrudescence (same strain) in developed nations and reinfection (new strain) in developing nations.
Discussion:
- Developed countries show a 46% decrease in H. pylori recurrence after the first year post-eradication, suggesting recrudescence is time-limited.
- Developing countries exhibit a persistent high rate of H. pylori reinfection, indicating ongoing exposure risks.
Key Insights:
- Annual H. pylori recurrence rates are 2.67% in developed and 13.00% in developing countries.
- Long-term follow-up reveals adjusted annual recurrence rates of 1.45% in developed and 12.00% in developing countries.
- The dominant mechanism of H. pylori recurrence shifts from recrudescence to reinfection based on geographic location.
Outlook:
- H. pylori eradication follow-up strategies require adaptation for developing countries due to high reinfection rates.
- Further research into the specific factors driving H. pylori reinfection in developing regions is warranted.
- Understanding geographic variations in H. pylori recurrence is crucial for effective patient management and public health interventions.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
891
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
1.5K
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.5K
01:28Peptic Ulcer Disease II: Pathophysiology
3.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
3.0K
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
1.0K
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
1.0K
01:27Peptic Ulcer
48
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
48
01:26Gastritis II: Pathophysiology
52
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
52
01:24Peptic Ulcer Disease II: Pathophysiology
44
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
44